BrainDTech logo

BrainDTech

Early detection and monitoring of neurological and neurodegenerative diseases in liquid biopsies.

4 employees · est. 2016 · Bresso, Italy

VS
Hedera Dx logo

Hedera Dx

Modern cancer care to the next billion people

31 employees · est. 2021 · Epalinges, Switzerland

BrainDTech is the older company (2016 vs 2021); Hedera Dx is the larger of the two.

Side-by-Side Comparison

BrainDTech Hedera Dx
Founded
2016 older 2021
Headquarters
Bresso, Italy Epalinges, Switzerland
Employees
4 31 larger
Industry
Biotechnology, Health Care, Life Sciences Health Care
Funding Stage
Series B Series A
Total Funding
$1.32M $29.00M
Funding Rounds
4 4
Services
Not tracked yet Liquid Biopsy Solutions, Tumor Profiling Kits, Software & Analysis for Cancer Treatment, Implementation Programs for Hospital Labs, Clinical Studies and Trials
Target Customers
Not tracked yet Hospital Laboratories, Oncologists, Healthcare Providers, Cancer Patients, Clinical Researchers
Taxonomy
Neurodegenerative Disease, Liquid Biopsies, MiRNA, Microglial Microvesicles, Medical Devices, Neurology Modern Cancer Care, Liquid Biopsy, Next-Generation Sequencing, Non-Invasive Diagnosis, Timely Treatment Selection, Longitudinal Disease Monitoring, Clinic-Ready Solutions, Tumor Profiling, IVD Compliance, Privacy Infrastructure, Precision Medicine, CtDNA, Medical Device, Oncology, Innovative Work Environment
Website
braindtech.com hederadx.com
BrainDTech logo

About BrainDTech

BrainDTech is a biotechnology startup founded in 2016, specializing in early detection and monitoring of neurological and neurodegenerative diseases in liquid biopsies. Their innovative approach is based on miRNA from microglial microvesicles. The company recently secured a €201.79K Series B investm...

Hedera Dx logo

About Hedera Dx

Hedera Dx, founded in 2021, is a Swiss-based startup in the Health Care industry, poised to revolutionize cancer diagnostics. With the slogan, "Modern cancer care to the next billion people," the company offers innovative NGS-based liquid biopsies. These non-invasive tests not only facilitate early...

We will tell you when either one moves

BounceWatch watches BrainDTech and Hedera Dx for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BrainDTech and Hedera Dx — by email.

Frequently Asked Questions

BrainDTech — Early detection and monitoring of neurological and neurodegenerative diseases in liquid biopsies.. Hedera Dx — Modern cancer care to the next billion people. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BrainDTech has raised $1.32M while Hedera Dx has raised $29.00M.
BrainDTech and Hedera Dx operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BrainDTech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BrainDTech on 19 Dec 2024, and Hedera Dx on 13 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy